HOUSTON, May 14, 2025 (GLOBE NEWSWIRE) -- Epsilon Energy Ltd. (“Epsilon” or the “Company”) (NASDAQ: EPSN) today reported first quarter 2025 financial and operating results. First Quarter 2025 Highlights: Epsilon - Q1 2025 Q1 2025Q4 2024Q1 2024QoQ%YoY%NRI Production <td colspan="2" style="border-right: solid black 1pt ; text-align: right ; vertical-align: mid ...

Core Insights - Journey Medical Corporation reported total net product revenues of $13.1 million for Q1 2025, consistent with $13.0 million in Q1 2024, with $2.1 million attributed to the launch of Emrosi [3][15] - The gross margin improved to 64% in Q1 2025 from 54% in the prior year, driven by lower product costs [3] - The company experienced a net loss of $4.1 million, or $(0.18) per share, for Q1 2025, a significant reduction from a net loss of $10.4 million, or $(0.53) per share, in Q1 2024 [3][21] Financial Performance - Cash and cash equivalents increased to $21.1 million as of March 31, 2025, compared to $20.3 million at the end of 2024 [3] - Research and development costs were nil in Q1 2025, down from $7.9 million in Q1 2024, which included pre-approval expenses for Emrosi [3] - Selling, general, and administrative expenses rose by $2.1 million to $10.6 million in Q1 2025, primarily due to activities related to Emrosi's launch [3] Product Launch and Market Position - Emrosi, an oral treatment for rosacea, had a strong launch with initial prescriptions filled in late March 2025 and was included in the updated National Rosacea Society Treatment Algorithms [2][10] - The Phase 3 clinical trial results for Emrosi were published in JAMA Dermatology, demonstrating statistical superiority over Oracea and placebo [2][10] - The company aims for sustainable positive EBITDA and profitability in 2025, viewing it as a transformational year [2] Corporate Developments - Journey Medical appointed Ramsey Alloush as Chief Operating Officer in April 2025 [10] - The company held a conference call on May 14, 2025, to discuss its financial results and strategic objectives [5][6]

Core Insights - Usio, Inc. reported a 34% increase in total payment dollars processed, reaching $2.0 billion in the first quarter of 2025 compared to $1.5 billion in the same period of 2024 [1][6] - The company achieved positive Adjusted EBITDA of $0.7 million, reflecting improved operational performance and strong cash management [2][4] - The growth in payment processing was primarily driven by a 42% increase in ACH electronic check dollar volume and a 36% increase in ACH transactions [2][7] Financial Performance - Revenues for the first quarter of 2025 were $22.0 million, up 5% from $20.97 million in the prior year, mainly due to strong growth in ACH and complementary services [3][8] - ACH and complementary services revenue grew by 30%, while credit card revenues increased by 4% and PayFac revenues surged by 25% [10][8] - Gross profit for the quarter was $4.8 million, with gross margins declining to 21.9% from 23.1% a year ago, primarily due to lower interest revenues [10][4] Operational Metrics - Total payment transactions processed in Q1 2025 reached 13.7 million, a 41% increase year-over-year [6] - The company set records in its credit card segment, with dollars processed up 17% and transactions processed up 65% compared to the previous year [7] - Operating cash flows improved significantly to $1.4 million from $0.1 million in the same period last year, driven by a reduction in accounts receivable [13] Strategic Outlook - The company has a strong implementation queue from signed deals, indicating potential for future revenue growth [2][5] - Usio is focused on expanding its market presence and strengthening its financial position, with a commitment to disciplined cost control [5][2] - The company ended the quarter with $8.7 million in cash and cash equivalents, reflecting a $0.7 million increase during the first three months of the year [13]

IRVING, Texas, May 14, 2025 (GLOBE NEWSWIRE) -- Sow Good Inc. (Nasdaq: SOWG) ("Sow Good" or "the Company"), a trailblazer in the freeze dried candy and treat industry, is reporting financial and operating results for first quarter ended March 31, 2025. "We're encouraged by the progress we made in the first quarter of 2025, particularly the successful everyday launches at Winn-Dixie, Ace Hardware, and Orville Hardware, as well as Holiday launches at Albertsons" said Claudia Goldfarb, CEO of Sow Good. "While ...

Core Insights - Creative Realities, Inc. reported a first quarter revenue of $9.7 million for fiscal 2025, down from $12.3 million in the same period of fiscal 2024, primarily due to installation timing issues [4][10] - The company announced a significant contract with a well-known restaurant chain to transform hundreds of locations across the U.S., which is expected to drive growth in the second half of 2025 [3][10] - The company ended the first quarter with an annual recurring revenue (ARR) of approximately $17.3 million, an increase from $16.8 million at the end of 2024 [5][10] Financial Performance - Consolidated gross profit for the first quarter was $4.5 million, compared to $5.8 million in the prior-year period, with a gross margin of 45.7% [5][10] - Operating loss for the first quarter was approximately $0.7 million, compared to a loss of $0.1 million in the same period last year [7][10] - The company reported a net income of $3.4 million, or $0.32 per diluted share, in the first quarter of fiscal 2025, compared to a net loss of $0.1 million, or $(0.01) per diluted share, in the prior-year period [7][10] Cost Management - Sales and marketing expenses decreased to $1.2 million from $1.5 million in the prior-year period, while general and administrative expenses fell to $3.9 million from $4.4 million [6][10] - Adjusted EBITDA for the first quarter was $0.5 million, down from $0.8 million in the prior-year period [8][10] Balance Sheet and Debt - As of March 31, 2025, the company had cash on hand of approximately $1.1 million, compared to $1.0 million at the end of 2024 [11][10] - Total debt was approximately $23.2 million, down from $25.8 million at the start of the fiscal year, primarily due to a $5.8 million reduction in contingent liabilities [11][10] - The trailing twelve-month gross and net leverage ratios utilizing Adjusted EBITDA were 4.91x and 4.67x, respectively, compared to 2.59x and 2.39x at the beginning of 2025 [12][10]

Financial Performance - Riskified's Q1 2025 revenue reached $82.4 million, an 8% year-over-year increase[51, 56] - The company achieved positive Adjusted EBITDA of $1.3 million in Q1 2025, marking the sixth consecutive quarter of positive Adjusted EBITDA[51, 58] - Riskified repurchased 4.1 million shares in Q1 2025 at a total cost of $20.7 million[59, 65] - The company maintains its 2025 revenue guidance between $333 million and $346 million, with an Adjusted EBITDA guidance between $18 million and $26 million[61] Business Growth & Diversification - Riskified's GMV for FY2024 was over $140 billion[16, 20] - Revenue from products outside of the core Chargeback Guarantee product increased by approximately 190% year-over-year[64] - The company is expanding into new verticals, including Money Transfer & Payments, which experienced over 90% year-over-year revenue growth in Q1 2025[63] - Riskified is diversifying geographically, with eight of the top ten new Chargeback Guarantee logos representing wins outside of the United States in Q1 2025[62] Platform & Technology - Riskified's platform has reviewed over 4 billion historical eCommerce transactions and includes over 950 million unique consumers in its network[40] - The company's non-GAAP operating expenses as a percentage of revenue decreased from 53% to 48% year-over-year, indicating improved expense management[57]

Core Insights - KP Tissue Inc. reported strong Q1 2025 financial results, with Adjusted EBITDA of $75.8 million, a 12.9% increase year-over-year, and revenue growth of nearly 14% [3][5][9] Financial Performance - Revenue for Q1 2025 was $546.1 million, up from $479.4 million in Q1 2024, marking an increase of $66.7 million or 13.9% [5][8] - Cost of sales increased to $451.0 million in Q1 2025 from $394.0 million in Q1 2024, reflecting a rise of $57.0 million or 14.5% [6] - Selling, general and administrative (SG&A) expenses rose to $51.2 million in Q1 2025, an increase of $7.1 million or 16.1% compared to Q1 2024 [7] - Net income for Q1 2025 was $15.4 million, compared to $9.0 million in Q1 2024, an increase of $6.4 million [10][12] Segment Performance - The Consumer segment revenue was $465.2 million in Q1 2025, up from $404.3 million in Q1 2024, while the Away-From-Home (AFH) segment revenue increased to $80.9 million from $75.1 million [36] - Adjusted EBITDA for the Consumer segment was $76.1 million, compared to $62.7 million in the previous year, while the AFH segment saw a decrease in Adjusted EBITDA to $2.8 million from $7.8 million [37] Operational Developments - The newly deployed LDC paper machine in Sherbrooke is expected to meet all in-house paper requirements starting Q2 2025, contributing to operational efficiency [3] - The company is closely monitoring the impact of changing tariffs on its business and has developed contingency plans [3] Liquidity and Dividends - Total liquidity as of March 31, 2025, was $356.8 million, with $4.4 million held for the Sherbrooke Expansion Project [11] - A quarterly dividend of $0.18 per share has been declared, to be paid on July 15, 2025 [13]

Core Insights - Sanara MedTech Inc. reported a 26% year-over-year increase in net revenue for Q1 2025, reaching $23.4 million compared to $18.5 million in Q1 2024 [6][10][15] - The company experienced a net loss of $3.5 million in Q1 2025, which is an increase from a net loss of $1.8 million in the same period last year [15][27] - Adjusted EBITDA improved to $0.7 million in Q1 2025, up from $0.3 million in Q1 2024, indicating better operational performance [16][32] Financial Performance - Net revenue increased by $4.9 million, driven by a $4.5 million (28%) rise in soft tissue repair products and a $0.4 million (18%) increase in bone fusion products [10][11] - Gross profit for Q1 2025 was $21.6 million, a 30% increase from $16.6 million in Q1 2024, with a gross margin of 92% compared to 90% in the previous year [11][12] - Operating expenses rose to $23.7 million, a 30% increase from $18.2 million in Q1 2024, primarily due to higher selling, general, and administrative expenses [12][13] Operational Developments - The company executed an exclusive license and distribution agreement with Biomimetic Innovations Ltd, acquiring U.S. marketing rights for a new bone void filler product [7][8] - Sanara expanded its executive leadership team with new appointments, including a new Chief Financial Officer [7][8] - The company is preparing to launch a pilot program for its Tissue Health Plus initiative in collaboration with a wound care provider group [8] Cash and Debt Position - As of March 31, 2025, Sanara had $20.7 million in cash and $42.8 million in principal debt obligations, with an additional borrowing capacity of $12.25 million [17][24] - The company borrowed $12.25 million under its term loan agreement, which may be used for acquisitions and working capital [7][17] Market Focus - Sanara MedTech is focused on developing transformative technologies in the surgical, chronic wound, and skincare markets, aiming to improve clinical outcomes and reduce healthcare costs [20][21] - The company markets a range of products in the advanced wound care and surgical tissue repair markets, with a strong emphasis on expanding its distribution network [20][21]

Financial Performance - Adjusted EBITDA for Q1 2025 was EUR 188.5 million, reflecting a 3.7% increase year-over-year, primarily driven by the Green Capacities and Networks segments [2][11] - Investments in Q1 2025 totaled EUR 146.5 million, a decrease of 30.1% year-over-year, with 48.7% allocated to Green Capacities [3][11] - The FFO LTM/Net Debt ratio decreased by 0.9 percentage points to 28.8% compared to the end of 2024, indicating strong leverage metrics [3][11] Business Development - The Green Capacities portfolio increased to 8.4 GW, with secured capacity at 3.1 GW and installed capacity at 1.4 GW [4] - Key milestones included the completion of Kelmė WF I (114.1 MW) and the acquisition of a hybrid development project (285 MW) in Lithuania [4] - The Networks segment saw investments of EUR 3.5 billion, a 40% increase, with over 1.1 million smart meters installed [5] Sustainability - The Green Share of Generation was 60.7%, a decrease of 19.3 percentage points year-over-year, attributed to higher generation from CCGT [6] - Total GHG emissions in Q1 2025 were 1.43 million t CO2-eq, a 22.8% increase year-over-year, with Scope 1 emissions rising significantly due to new services [7][8] Shareholder Returns and Outlook - A dividend of EUR 0.663 per share was paid for H2 2024, totaling EUR 48.0 million [9] - The company maintains its full-year 2025 Adjusted EBITDA guidance of EUR 500–540 million and investment guidance of EUR 700–900 million [10]

Core Insights - TWFG, Inc. reported a strong first quarter performance with total revenues increasing by 16.6% year-over-year to $53.8 million and total written premium rising by 15.5% to $371.0 million [1][5][8] - The company achieved an organic revenue growth rate of 14.3%, indicating robust new business production and effective agent productivity [1][6][8] - Adjusted EBITDA increased by 35.3% to $12.2 million, with an adjusted EBITDA margin expanding to 22.6% [1][11][38] Financial Performance - Net income for the quarter was $6.9 million, slightly up from $6.6 million in the prior year, resulting in a net income margin of 12.7% [1][10][11] - Adjusted net income rose to $9.2 million, with an adjusted net income margin of 17.1% [1][10][11] - Cash flow from operating activities improved to $15.6 million, compared to $9.8 million in the previous year [11] Business Expansion - The company expanded its national footprint by acquiring two new corporate locations and adding 17 branches across the U.S. [4] - The newly onboarded agents are expected to take two to three years to reach full productivity, indicating a long-term growth strategy [4] Key Performance Indicators - Total written premium for the first quarter was $371.0 million, with insurance services contributing significantly [32][39] - The breakdown of total written premium showed that personal lines accounted for 80% and commercial lines for 20% [39] - The company reported a written premium retention rate of 88% for insurance services and 82% for TWFG MGA [39]